Articles that mention Merck -BoardProspects

Merck

0 Comments Leave a Comment

1-15 of 41 1 2 3 »
1. Mentioned In 41 Articles
2. DowDuPont Announces New Members for Future Board of Directors of DuPont
  
  Explore PR Newswire Apr 17 2019 BoardMoves
  
  ...cialty Products Division of DowDuPont. The new directors includeFrank K. Clyburn, chief commercial officer at Merck Co., Inc.,Terrence R. Curtin, CEO of TE Connectivity, andFrederick M. Lowery, senior vice president and...
  Read Full Article
  
  Comment
  
  Mentions: DuPont DowDupont NYSE
3. Versum Materials’ Board of Directors Rejects Unsolicited Tender Offer from Merck KGaA
  
  Explore businesswire.com Mar 29 2019 BoardNews
  
  ... financial and legal advisors, unanimously determined to reject the unsolicited tender offer from Merck KGaA (Merck) to acquire all outstanding shares of Versum for $48 per share in cash (the Offer). The Versum Board det...
  Read Full Article
  
  Comment
  
  Mentions: NYSE Merck Versum Materials
4. Inovio Appoints Global Commercial Leader to its Board of Directors
  
  Explore MarketWatch Mar 25 2019 BoardMoves
  
  ... of Directors. Dr. Miller had an outstanding marketing career launching and building blockbuster products for Merck, Amgen, Eisai and Sanofi. While at Sanofi, she led the Sanofi Oncology Global Marketing function includi...
  Read Full Article
  
  Comment
  
  Mentions: Management Sanofi Amgen
5. Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?
  
  Explore Yahoo! Finance Mar 15 2019 BoardBlogs
  
  ...ar indication. Opdivo's failure in that indication is a sore spot for Bristol-Myers investors because, unlike Merck -- which only enrolled patients expressing high levels of PD-1 in Keytruda's trial -- Bristol-Myers enro...
  Read Full Article
  
  Comment
  
  Mentions: Management Investors acquisition
6. Prodoscore Appoints Sam Naficy as Chairman of the Board
  
  Explore businesswire.com Mar 7 2019 BoardMoves
  
  ...ing its first 18 months Daru Nardin attained the exclusive distribution rights to Merck Sharpe & Dohme (MSD — Merck) and Faulding Pharmaceuticals (one of Australia’s largest pharmaceutical companies) for sales into Iran....
  Read Full Article
  
  Comment
  
  Mentions: Google NYSE Founder
7. Bristol-Myers Urges Shareholders in Open Letter to Support $74 Billion Celgene Deal Amid Resistance
  
  Explore CNBC.com Mar 6 2019 BoardNews
  
  ... gives Bristol more cancer drugs at a time when its immuno-oncology portfolio struggles to keep up with rival Merck's Shareholders will vote on the proposed acquisition next month. The company on Wednesday reiterated tha...
  Read Full Article
  
  Comment
  
  Mentions: Management acquisition Bristol-Myers Squibb
8. Versum Materials Board of Directors Rejects Unsolicited Proposal from Merck KGaA
  
  Explore businesswire.com Mar 1 2019 BoardNews
  
  ...pplier to the semiconductor industry, today announced that its Board of Directors has rejected Merck KGaA’s (“Merck”) unsolicited and non-binding proposal, received on February 27, 2019, to acquire Versum for $48 per sha...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Investors SEC
9. If the CEO is Overpaid, Blame the Compensation Committee
  
  Explore MIT Sloan Experts Blog Feb 27 2019 BoardBlogs
  
  ...sation reports, which may use only the adjusted numbers without quantifying their differences from GAAP. Take Merck & Co., whose CEO had a bonus goal for 2015 of $3.40 in adjusted earnings per share. The compensation com...
  Read Full Article
  
  Comment
  
  Mentions: Executive Compensation Management Wall Street
10. Synlogic Appoints Patricia N. Hurter, Ph.D. to Board of Directors
  
  Explore businesswire.com Feb 12 2019 BoardMoves
  
  ...® and Symdeko®. Prior to joining Vertex, Dr. Hurter was Director, Formulation Design and Characterization for Merck where she was a key member of the early development team for Januvia®, a treatment for Type II diabetes....
  Read Full Article
  
  Comment
  
  Mentions: Board of Trustees SEC Nasdaq
11. Mary Ellen Coe Elected to Merck Board of Directors
  
  Explore businesswire.com Feb 2 2019 BoardMoves
  
  ...s in connection with Mercks Annual Meeting of Shareholders on May 28, 2019. With the addition of Ms. Coe, the Merck board will include 13 members... ...
  Read Full Article
  
  Comment
  
  Mentions: Annual Meeting Google NYSE
12. Corporate Governance And The Widening Gyre
  
  Explore forbes.com Jan 14 2019 BoardBlogs
  
  ...cutives are increasingly recognizing the challenges confronting business in the current maelstrom. Some, like Merck’s Kenneth Frazier, view it as “an opportunity to help bridge some of these chasms in understanding in ou...
  Read Full Article
  
  Comment
  
  Mentions: Sustainability Corporate Governance crisis
13. Bristol-Myers Squibb is Buying Celgene in a $74 Billion Deal
  
  Explore Business Insider Jan 3 2019 BoardNews
  
  ...uster cancer treatment, Revlimid. Bristol-Myers, for its part has faced stiff competition from companies like Merck in an area of cancer treatment known as cancer immunotherapy. BMS's drugs, Opdivo and Yervoy, harness th...
  Read Full Article
  
  Comment
  
  Mentions: acquisition Bristol-Myers Squibb Merck
14. Activist Investor Elliott Has Taken Position in Germany's Bayer
  
  Explore SHARENET Dec 7 2018 BoardNews
  
  ...y of Eli Lilly, unlisted Boehringer Ingelheim, which acquired animal health assets from Sanofi, and drugmaker Merck & Co. (Writing by Ludwig Burger Editing by Douglas Busvine and David Holmes) 2018-12-07 20:02:53 ...
  Read Full Article
  
  Comment
  
  Mentions: Activist Investors Investors Sanofi
15. Data Privacy And Cybersecurity Issues In Mergers And Acquisitions
  
  Explore forbes.com Nov 11 2018 BoardBlogs
  
  ...ctive attack, destroyed entire networks and systems for some of the largest companies in the world, including Merck, Maersk, and FedEx, and cost companies worldwide an estimated $10 billion in damages. On a smaller scale...
  Read Full Article
  
  Comment
  
  Mentions: Mergers and Acquisitions SEC Cybersecurity
16. Medidata Appoints Dr. Maria Rivas to its Board of Directors
  
  Explore Business Wire Oct 22 2018 BoardMoves
  
  ...anies and is currently the Senior Vice President, Head of Global Medical Affairs at the biopharma business of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the U.S. and Canada. About Medidata Medidata i...
  Read Full Article
  
  Comment
  
  Mentions: Women on Boards Nasdaq risk
17. 1-15 of 41 1 2 3 »